MIRM earnings: a positive outcome, +11.8%

On August 4, 2022, Mirum Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.8% in the window around the event. It had already run +6.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.